Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CiVi Biopharma, Inc. logo — company profile

CiVi Biopharma, Inc.

Founded 2016 United States United States 10 employees

General Information

Company Name CiVi Biopharma, Inc.
Founded Year 2016
Location United States United States +2
Employees 10
Social

Get notified when CiVi Biopharma, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CiVi Biopharma, Inc.

CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVi’s innovative pipeline includes CiVi007, a long-acting PCSK9 third-generation Locked Nucleic Acid antisense molecule being developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, the Company currently has other clinical stage development program activity aimed at treating severe liver diseases.

No funding data available for CiVi Biopharma, Inc. yet.

Get notified when CiVi Biopharma, Inc. raises funding

CiVi Biopharma, Inc. Alternatives & Competitors

CiVi Biopharma, Inc. vs
ARCA biopharma
ARCA biopharma

Personalized therapies for cardiovascular disease through advanced genetic research

Post Ipo Equity
Biotechnology, Health and Wellness
CiVi Biopharma, Inc. vs
ArteryFlow Technology
ArteryFlow Technology China

Bringing Precision to Medicine

Series B
21 employees
Health Care, Manufacturing
CiVi Biopharma, Inc. vs
CV Therapeutics
CV Therapeutics United States

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the...

Undisclosed
468 employees
Biotechnology, Health Care

FAQ About CiVi Biopharma, Inc.

CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVi’s innovative pipeline includes CiVi007, a long-acting PCSK9...
CiVi Biopharma, Inc. was founded in 2016.
CiVi Biopharma, Inc. is headquartered in United States.
CiVi Biopharma, Inc. has approximately 10 employees.
Top alternatives and competitors to CiVi Biopharma, Inc. include ARCA biopharma, ArteryFlow Technology, CV Therapeutics, Cereno Scientific, vasopharm GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CiVi Biopharma, Inc. and ARCA biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CiVi Biopharma, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes